Fundraising FoxFast Track Initiative — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
RegCell Biosciences is a biotechnology company developing regenerative cell therapies, leveraging expertise in cell and gene therapy, manufacturing, and immunology to advance therapeutic treatments.
BiotechDeep TechMedical Devices
Michael McCullar, PhD(Chief Executive Officer)James Ahlers(Chief Financial Officer)Marty Giedlin, PhD(Chief Technology Officer)Tony Hurley(Chief Technical Operations Officer)Steve Kanner, PhD(Chief Scientific Officer)
Co-investorsGlobal BrainKyoto University Innovation CapitalUTECMitsubishi UFJ CapitalOSAKA University Venture Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.